Gennova dismisses trial protocol violation allegations, to submit data of mRNA COVID-19 vaccine to drug regulator soon, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Even after clearance for stockpiling more than 21 lakh doses of m-RNA COVID-19 vaccine doses from the Central Drugs Laboratory (CDL) Kasauli, the Pune-based pharma company, Gennova has been alleged to have violated the clinical trial protocol., Even after clearance for stockpiling more than 21 lakh doses of m-RNA COVID-19 vaccine doses from the Central Drugs Laboratory (CDL) Kasauli, the Pune-based pharma company, Gennova has been alleged to have violated the clinical trial protocol., , Read More